Sala, E <br/><br/>
Recurrence of hyperprolactinemia following dopamine agonist withdrawal and possible predictive factors of recurrence in prolactinomas.  [electronic resource] 

 -  Journal of endocrinological investigation  Dec 2016 
 - 1377-1382 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1720-8386 
<br/><br/><label>Standard No.: </label>10.1007/s40618-016-0483-z  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Biomarkers--blood<br/>Cabergoline<br/>Dopamine Agonists--therapeutic use<br/>Ergolines--therapeutic use<br/>Female<br/>Humans<br/>Hyperprolactinemia--diagnosis<br/>Male<br/>Middle Aged<br/>Neoplasm Recurrence, Local--diagnosis<br/>Pituitary Neoplasms--complications<br/>Prognosis<br/>Prolactinoma--complications<br/>Tomography, X-Ray Computed--methods<br/>Withholding Treatment